Key result
9-methylstreptimidone inhibits viral growth at /ml in vitro and demonstrates bioretention in mice.
Why the study?
A new antiviral agent inhibiting poliovirus, VSV, and NDV growth was isolated from Streptomyces culture filtrate and characterized.
9-methylstreptimidone is a newly isolated antiviral antibiotic that demonstrates inhibition of several viruses, including poliovirus, in vitro and in vivo.
Answers are grounded in this paper and cite their sources.
Not ready for clinical use; leaves open further evaluation of this microbial antiviral lead.
A new antiviral agent which inhibits the growth of poliovirus, vesicular stomatitis virus (VSV) and Newcastle disease virus (NDV) was isolated from the culture filtrate of a Streptomyces and shown to be 3-(5, 7-dimethyl-4-oxo-2-hydroxy-6, 8-decadienyl)-glutarimide. The actue LD50 of the antibiotic in mice by intraperitoneal injection was 280 mg/kg. Serum specimens taken 10 minutes after intraperitoneal injection of 2.5 mg/kg to mice inhibited the growth of poliovirus.
No takes yet. Share an insight, caveat, or question.
Saito et al. (1974) studied Viral infection (preclinical). 9-methylstreptimidone was evaluated on Minimum inhibitory concentration (MIC) for viral plaque formation and acute LD50 in mice. 9-methylstreptimidone, a newly isolated antibiotic, inhibited the growth of poliovirus, vesicular stomatitis virus, and Newcastle disease virus at /ml in vitro and demonstrated bioretention in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: